{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:06:49Z","timestamp":1762866409213},"reference-count":22,"publisher":"SLACK, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND AND OBJECTIVE:<\/jats:title>\n            <jats:p>To determine the effectiveness and direct medical costs of treat-and-extend (TAE) intravitreal bevacizumab (IVB) for the treatment of branch retinal vein occlusion (BRVO)\u2013associated macular edema (ME).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS AND METHODS:<\/jats:title>\n            <jats:p>Retrospective chart review of 52 consecutive patients diagnosed with BRVO-associated ME treated with IVB using a TAE protocol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              Mean change in logMAR vision was \u22120.30 (\n              <jats:italic>P<\/jats:italic>\n              &lt; .001), and mean change in central macular thickness was \u2212244.0 \u03bcm (\n              <jats:italic>P<\/jats:italic>\n              &lt; .001). The mean number of injections was 8.2 (95% CI; 7.8 to 8.6). The yearly average direct cost of the TAE regimen was calculated to be $2,580.26 per patient.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Treatment of BRVO-associated ME with IVB using a TAE regimen resulted in similar visual outcomes and number of intravitreal injections as did as-needed treatment with 0.5 mg ranibizumab conducted in phase 3 trials but with fewer visits and lower annual medical costs.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                [\n                <jats:italic>Ophthalmic Surg Lasers Imaging Retina<\/jats:italic>\n                . 2014;45:212\u2013216.]\n              <\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/23258160-20140404-01","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T16:56:45Z","timestamp":1400518605000},"page":"212-216","source":"Crossref","is-referenced-by-count":23,"title":["Treat-and-Extend Intravitreal Bevacizumab for Branch Retinal Vein Occlusion"],"prefix":"10.3928","volume":"45","author":[{"given":"Ryan B.","family":"Rush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Simunovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Antonio V.","family":"Aragon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Edward","family":"Ysasaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.4.513"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(84)90316-7"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-010-0089-3"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000337157"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.03.060"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.022"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.02.022"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S19279"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0916-2"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-301992"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318195ca65"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.233"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.032"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181de5609"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.08.011"},{"key":"e_1_3_1_17_2","unstructured":"Population by age and sex: 2010. In: Census Briefs Bureau USC ed. 2011."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000254893.94013.16"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-197611000-00006"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.12.005"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.042"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.015"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/23258160-20140404-01","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:55:40Z","timestamp":1683086140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/23258160-20140404-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3928\/23258160-20140404-01"],"URL":"https:\/\/doi.org\/10.3928\/23258160-20140404-01","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}